Please login to the form below

Not currently logged in
Email:
Password:

DARPin

This page shows the latest DARPin news and features for those working in and with pharma, biotech and healthcare.

Allergan will start phase III DARPin trials next year

Allergan will start phase III DARPin trials next year

Allergan will start phase III DARPin trials next year. Will investigate drug in wet age-related macular degeneration. ... Allergan confirmed yesterday it will start pivotal trials of its DARPin treatment for wet age-related macular degeneration (AMD) in

Latest news

More from news
Approximately 2 fully matching, plus 6 partially matching documents found.

Latest Intelligence

  • Deal Watch January 2018

    Collaboration, licence. 830. Molecular Partners/ Allergan. Option exercise for 2 DARPins from Allergan's ophthalmology alliance signed in 2012.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics